Large-scale testing (Phase 3)Ended earlyNCT00596492
What this trial is testing
DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
Who this might be right for
Mature Cataracts
Aqumen Biopharmaceuticals, N.A. 200